4.8/10
Weak

DSIP

DSIP · Neuropeptide · Longevity / Sleep

The sleep peptide with a strong name and a much softer evidence base. Worth understanding, not worth pretending is proven. Curious, still thin.

Cost / mo
$50–90
Forms
SubQ
Onset
Days to 2 weeks
Cycle
2–6 weeks
Studies
10 or fewer

Should you care about DSIP?

You should care if you are comparing experimental sleep peptides and want to know which ones have more mythology than proof. DSIP belongs on that list.

You should stay conservative because sleep help is not the same as strong sleep evidence. DSIP is better treated as an edge case than a first-line answer.

What the internet says

"DSIP knocks almost everyone out if the dose is high enough."

What the data says

The response is inconsistent, and raising the dose does not turn thin evidence into a reliable intervention.

What it actually does (ranked by evidence)

1

Sleep SupportWeak

This is still the primary reason anyone uses DSIP. The problem is that the literature does not support confidence at the level the name implies.

2

Stress-Modulation SupportWeak

Plausible, but very much secondary to the already-uncertain sleep case.

Dosing

Experimental use. Do not confuse an evocative peptide name with a mature sleep-medicine evidence base.
Oral
No standard oral form

DSIP is usually discussed in injectable bedtime protocols rather than non-invasive formats.

Injectable
100–300 mcg nightly

Short cycles are common because confidence is limited and practical benefit is often tested quickly.

If sleep hygiene, caffeine timing, or stress load are off, it becomes even harder to tell what the peptide is doing.

Side effects: the honest version

✓ Confirmed safe
  • ✓Morning grogginess
  • ✓Dizziness or lightheadedness
  • ✓Injection-site irritation
! Unknown
  • iResponse appears inconsistent across users.
  • iSleep benefits are easy to over-read when routines are changing at the same time.
  • iThe evidence base is too thin for strong confidence.

The studies that matter

We read all 8+. These are the three we'd cite first.

Historical DSIP sleep-regulation literature

Weak
Older neuropeptide research · 1980s–2000s
Result: Mixed signal around sleep outcomes and physiological role

Stress and neuroregulatory observations

Weak
Experimental translational reports · 2000s–2010s
Result: Interesting hypotheses, limited practical certainty
View all 8+ studies

How it stacks up

Longevity peptide comparison. No hedging.

DSIP
Ipamorelin
Selank
Score
4.8
7
6.3
Evidence
Weak
Moderate
Moderate
Oral?
No
No
No
Cost / mo
$50–90
$80–140
$70–120
Best for
Sleep support in experimental protocols
Sleep and GH support
Stress and calm support
Our pick?
Situational
Stronger protocol case
Different angle

Questions people actually ask

Answers that don't insult your intelligence.

No. It is better described as an experimental sleep peptide with mixed evidence than as a proven insomnia treatment.
★ Bottom Line

DSIP is one of those peptides that sounds more settled than it is. Interesting enough to compare, too weak to sell with confidence.

— PepTalk Editorial Team · April 2026